Metformin (generic), Glucophage News Archives

Want to save billions of dollars on America's health bill? Cut the rate at which people come down with diabetes.

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.

Anational 10-year study that included Hawaii participants reports that intensive lifestyle changes aimed at modest weight loss and increased physical activity reduced the rate of developing type 2 diabetes by 34 percent.

The London News.Net Thursday 29th October, 2009 London, October 29 : The best possible way to keep diabetes at bay is to maintain a healthy lifestyle with a balanced diet and ingestion of everyday cheap pill, according to a new US study.

An article published Online First and in a future edition of The Lancet reports that prevention or delay of type 2 diabetes with lifestyle intervention or metformin can persist for at least ten years.

A fishery scientist who is one of 60 isle participants in a 10-year national study on diabetes prevention said he lost weight and has better health because of it.

Healthy habits and weight loss can delay diabetes for 10 years in high-risk people, a new study has found.

Regulatory News: Ipsen , an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 analogue originating from Ipsen's Research.

Diet and exercise can keep diabetes at bay for a decade, cutting the risk for the disease by more than a third in the most susceptible people, a new study finds.

A period of careful eating and regular exercise can stave off diabetes for a decade, a study suggests.

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.

Type 2 diabetics on oral therapy appear to benefit most from the addition of basal insulin-based therapy, as compared to a prandial or biphasic insulin-based program, according to research published online Oct.

In patients with refractory type 2 diabetes, the addition of certain insulin regimens seems to offer better control and fewer complications, reports the New England Journal of Medicine .

Medications for Type 2 diabetes are very effective at controlling blood sugar levels.

Long-acting insulin works better than other types of injections for people who need more than pills for their type 2 diabetes, researchers reported on Thursday.

Correspondence: Dr DE Wilfley, WUSM, Campus Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA.

Bristol-Myers Squibb Company and AstraZeneca announced the launch of ONGLYZA in the UK for the treatment of Type 2 diabetes in adults, as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.

DEERFIELD, Ill. Type 2 diabetes patients treated with a therapy that combines a branded drug and a widely available generic experienced greater blood sugar reduction than patients who took either drug alone, according to results of a recent clinical study.

Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients having a history of MI, according to a comprehensive Danish national cohort study.

NEW YORK A new study found that alcohol intake may reduce risk of diabetes incidence, and may lower insulin secretion for those on a diabetes-prevention regimen.

A study recently completed at UT Southwestern Medical Center suggests that those fears are largely unfounded and that patients and physicians should consider insulin as a front-line defense, as opposed to a treatment of last resort for non-insulin-dependent diabetes.

I'm 33 , DH is 31 and we just found out we are pregnant with our first child. It was quite unexpected...as we weren't TTC because I have been trying to lose weight and get my health issues under control.

Updated June 13, 2006 Lactic Acidosis The buildup of lactic acid in the bloodstream.

A new drug for type 2 diabetes has shown the ability to lower both HbA1c levels fasting plasma glucose in patients who have not achieved good blood glucose control using metformin alone.

Analyst Report ) announced that their diabetes drug Onglyza received the green light from the European Commission to be marketed in the 27 countries of the European Union .

Analyst Report ) announced that its diabetes drug dapagliflozin, in combination with metformin , significantly reduced levels of glycosylated haemoglobin which is an indication of glucose concentration in the blood in type II diabetes patients as compared to placebo plus metformin in a late-stage study.

A University of KwaZulu-Natal pharmacologist has discovered that grapefruit juice can be bad for people on a certain diabetes medication, the university said on Wednesday.

Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.

PRINCETON,A N.J. A late-stage clinical trial found that a diabetes treatment combined with metformin worked just as well as a similar drug.

The next breakthrough breast cancer treatment may be a diabetes drug already on the shelves of nearly every pharmacy.

A cheap and safe pill taken by millions of diabetics could hold the secret of a long and healthy life.

Oct 2, 2009 - Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level and in the secondary endpoint, fasting plasma glucose in patients with type 2 diabetes inadequately controlled with ...

An experimental diabetes drug from Bristol-Myers Squibb and AstraZeneca met its main target in a late stage study, achieving significant reductions in glycosylated hemoglobin levels.